Skip to main content

Published locations for Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitors

User login

  • Reset your password
  • /content/rheumatoid-arthritis-higher-risk-mace-and-cancer-tofacitinib-vs-tnf-inhibitors
  • /rheumatology/article/252177/rheumatoid-arthritis/rheumatoid-arthritis-higher-risk-mace-and-cancer